Oncology and Hematology
Episodes 1-16 of 300
- Project Oncology®
Best Practices for Utilizing Shared Decision-Making in CLL Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
- Project Oncology®
Navigating CLL Treatment: A Deep Dive into Efficacy and Safety
John Russell, MD
Seema A. Bhat, MD
- Project Oncology®
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Jennifer Caudle, DO
Sarah Rutherford, MD
Charles Turck, PharmD, BCPS, BCCCP
Seema A. Bhat, MD
Joanna Rhodes, MD, MSCE
- Project Oncology®
The CLL Landscape: A Look at Current and Future Therapies
John Russell, MD
Andrew H. Lipsky, MD
- Project Oncology®
CLL Treatment: Managing Uncertainty Through Effective Communication
John C. Byrd, MD
Charles Turck, PharmD, BCPS, BCCCP
Tara Graff, DO, MS
- Project Oncology®
Monitoring Treatment Reponses in CLL: A Review of Key Protocols
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
Charles Turck, PharmD, BCPS, BCCCP
Richard R. Furman, MD
Javier Pinilla, MD, PhD
Matthew Lunning, DO, FACP
- Project Oncology®
Personalizing Relapsed/Refractory CLL Care: Key Factors to Consider
Charles Turck, PharmD, BCPS, BCCCP
Lindsey Roeker, MD
Charles Turck, PharmD, BCPS, BCCCP
Adam Kittai, MD
- Project Oncology®
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Caitlin Costello, MD
Sagar Lonial, MD, FACP
- Project Oncology®
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
- Prev
- Next